Core Viewpoint - Hai Jiaya Medical (06078) issued a profit warning, leading to a decline of over 5% in its stock price, currently trading at HKD 15.22 with a transaction volume of HKD 52.01 million [1] Financial Performance Summary - For the six months ending June 30, 2025, the company expects a revenue decline of approximately 15% to 17% compared to the same period last year [1] - Net profit is anticipated to decrease by about 34% to 39% year-on-year [1] - Adjusted net profit, based on non-International Financial Reporting Standards, is projected to fall by around 32% to 37% compared to the previous year [1] - Cash generated from operating activities is expected to increase by approximately 28% to 32% year-on-year [1] Industry Impact Summary - The decline in revenue, net profit, and adjusted net profit is primarily attributed to industry factors such as centralized procurement, DRG payment reforms, and macroeconomic influences [1] - The increase in depreciation and amortization from newly opened hospitals also contributed to the financial downturn [1]
海吉亚医疗盈警后跌超5% 预计中期净利润同比下降约34%至39%